acetylcysteine and Bronchopulmonary Dysplasia

acetylcysteine has been researched along with Bronchopulmonary Dysplasia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Abdelghany, O; Bahtiyar, MO; Bhandari, V; Buhimschi, CS; Buhimschi, IA; Dulay, AT; Lipkind, HS; Mieth, S; Razeq, SA; Rogers, L; Schneider, L; Zhao, G	1
Lin, HC; Ma, L; Neu, J; Zhou, P	1
Fellman, V; Hjalmarson, O; Sandberg, K; Stigson, L; Thiringer, K	1

Reviews

1 review(s) available for acetylcysteine and Bronchopulmonary Dysplasia

Article	Year
Potential Nutrients for Preventing or Treating Bronchopulmonary Dysplasia. Paediatric respiratory reviews, 2017, Volume: 22 Topics: Acetylcysteine; Antioxidants; Arginine; Bronchopulmonary Dysplasia; Citrulline; Cysteine; Fatty Acids, Unsaturated; Glutamine; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Infant, Premature; Inositol; Selenium; Vitamin A; Vitamin B Complex	2017

Trials

2 trial(s) available for acetylcysteine and Bronchopulmonary Dysplasia

Article	Year
Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial. Pediatric research, 2021, Volume: 89, Issue:1 Topics: Acetylcysteine; Adult; Apgar Score; Bronchopulmonary Dysplasia; Chorioamnionitis; Connecticut; Drug Administration Schedule; Female; Gestational Age; Hospital Mortality; Humans; Infant; Infant Mortality; Infant, Premature; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult	2021
N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants. Biology of the neonate, 2004, Volume: 86, Issue:4 Topics: Acetylcysteine; Bronchopulmonary Dysplasia; Glutathione; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lung; Lung Compliance; Placebos; Respiratory Function Tests	2004

Article

Year

Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial.

Pediatric research, 2021, Volume: 89, Issue:1

Topics: Acetylcysteine; Adult; Apgar Score; Bronchopulmonary Dysplasia; Chorioamnionitis; Connecticut; Drug Administration Schedule; Female; Gestational Age; Hospital Mortality; Humans; Infant; Infant Mortality; Infant, Premature; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Premature Birth; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult

2021

N-acetylcysteine administration during the first week of life does not improve lung function in extremely low birth weight infants.

Biology of the neonate, 2004, Volume: 86, Issue:4

Topics: Acetylcysteine; Bronchopulmonary Dysplasia; Glutathione; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care, Neonatal; Lung; Lung Compliance; Placebos; Respiratory Function Tests

2004